查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888590

全球多重檢測試劑市場：市場規模、佔有率、趨勢分析（按類型、應用、最終用途和地區分類）、細分市場預測（2025-2033 年）

Multiplex Testing Reagents Market Size, Share & Trend Analysis By Type (Biotin-based Reagents, Streptavidin-based Reagents), By Application (Autoimmune Disease Diagnostics, Oncology), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

多重檢測試劑：市場概覽

2024年全球多重檢測試劑市場規模估計為14.2億美元，預計2033年將達到41.5億美元。

預計從 2025 年到 2033 年，其複合年成長率將達到 13.08%。多重檢測試劑能夠在一次檢測中同時檢測多種分析物，與傳統的單一標靶檢測相比，具有更高的效率和成本效益。

由於能夠在短時間內提供全面的診斷數據，多重檢測技術已被廣泛應用於臨床、科研和製藥領域。此外，個人化醫療的需求日益成長，快速且準確地檢測多種生物標記對於制定個人化的治療方案至關重要，這也推動了市場成長。檢測設計、自動化和檢測平台的技術進步也提高了多重檢測的可靠性和通量，使其成為實驗室最佳化工作流程、最大限度減少樣本量和營運成本的理想選擇。

推動多重檢測試劑成長的關鍵因素是全球慢性病和感染疾病的日益普及。心血管疾病、癌症、自體免疫免疫疾病和代謝症候群等慢性疾病通常涉及多種生物標記物，因此多重檢測成為全面監測和診斷的有效工具。此外，包括病毒、細菌和新興病原體在內的感染疾病在全球範圍內日益加重，也促使人們需要能夠同時檢測多種病原體的高通量診斷解決方案。多重檢測試劑使臨床醫生篩檢合併感染並識別病原體譜，從而減少診斷延遲。這在公共衛生領域尤其重要，因為早期發現對於預防感染傳播至關重要。因此，疾病盛行率的上升與多重檢測試劑的日益普及直接相關，並推動了市場擴張。

技術創新是推動多重檢測試劑市場成長的主要因素。先進的檢測平台，例如以微珠為基礎的流式細胞技術、微陣列和與次世代定序相容的試劑，正在提高多重檢測的靈敏度、特異性和通量。自動化和與實驗室資訊系統 (LIS) 的整合進一步簡化了工作流程，使檢查室能夠在處理更大檢體量的同時減少人為錯誤。新型試劑化學和標記技術提高了低表達生物標記檢測的準確性，拓展了其臨床和研究應用範圍。此外，小型化和微流體技術實現了照護現場檢測 (POC)，使患者能夠更便捷地獲得檢查室級的分析。這些技術進步不僅提高了診斷準確性，還縮短了檢測結果返回的時間並降低了成本，使得多重檢測試劑對全球醫院、診斷檢查室和研究機構更具吸引力。

目錄

第1章：多重檢測試劑市場：分析方法與範圍

2. 多重檢測試劑市場：執行摘要

  • 市場概覽
  • 按類型
  • 應用概述
  • 最終用途概述
  • 競爭格局概述

第3章：多重檢測試劑市場：影響因素、趨勢與範圍

  • 市場區隔/範圍
  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 精準診斷和個人化醫療的需求日益成長
    • 多重檢測平台的技術進步
    • 加大藥物發現與轉化研究的研發投入
  • 市場限制因素分析
    • 多重檢測所需的試劑和設備高成本
    • 複雜的檢驗和標準化挑戰
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章：多重檢測試劑市場：按類型分類的估算與趨勢分析

  • 多重檢測試劑市場：按類型分類的差異分析
  • 多重檢測試劑市場：按類型分類的展望
  • 生物素基試劑
    • 生物素化抗體
    • 生物素標記探針/引物
    • 生物素標記的蛋白質/酶
  • 基於鏈黴親和素的試劑
    • 鏈黴親和素偶聯的磁珠/微球
    • 鏈黴親和素偶聯酶和螢光染料
    • 重組鏈黴親和素突變體經基因工程改造以提高穩定性
  • 其他

第5章：多重檢測試劑市場：按應用分類的估算與趨勢分析

  • 多重檢測試劑市場：按應用分類的差異分析
  • 多重檢測試劑市場：按應用領域分類的展望
  • 自體免疫疾病診斷
  • 感染疾病診斷
  • 瘤
  • 過敏測試
  • 研究與轉譯醫學
  • 藥物發現與開發
  • 其他

第6章：多重檢測試劑市場：依最終用途分類的估算與趨勢分析

  • 多重檢測試劑市場：依最終用途分類的差異分析
  • 多重檢測試劑市場：依最終用途分類的展望
  • 臨床和診斷檢查室
  • 醫院
  • 製藥和生物技術公司
  • CRO（委外研發機構）
  • 學術和研究機構

第7章 多重檢測試劑市場：按地區分類的業務分析

  • 市場概覽：按地區分類
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 商業夥伴關係
    • 企業收購
    • 商業合作
    • 資金籌措
  • 主要企業市佔率分析（2024 年）
  • 公司熱力圖分析
  • 公司簡介
    • Luminex Corporation
    • Bio-Rad Laboratories, Inc.
    • Abcam plc.
    • Seegene Inc.
    • Merck KGaA
    • Illumina, Inc.
    • Promega Connections
    • QIAGEN NV
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Bio-Techne Corporation
    • BD
Product Code: GVR-4-68040-793-6

Multiplex Testing Reagents Market Summary

The global multiplex testing reagents market size was estimated at USD 1.42 billion in 2024 and is expected to reach USD 4.15 billion by 2033, growing at a CAGR of 13.08% from 2025 to 2033. Multiplex testing reagents enable the simultaneous detection of multiple analytes in a single test, offering higher efficiency and cost-effectiveness compared to conventional single-target assays.

Their ability to provide comprehensive diagnostic data in shorter timeframes has driven adoption across clinical, research, and pharmaceutical applications. The market's growth is further fueled by the increasing demand for personalized medicine, where rapid and precise detection of multiple biomarkers is critical for tailoring treatment strategies. Technological advancements in assay design, automation, and detection platforms have also enhanced the reliability and throughput of multiplex testing, making it an attractive choice for laboratories aiming to optimize workflow while minimizing sample volume and operational costs.

A primary factor driving the growth of multiplex testing reagents is the rising prevalence of chronic diseases and infectious conditions worldwide. Chronic illnesses such as cardiovascular disorders, cancer, autoimmune diseases, and metabolic syndromes often involve multiple biomarkers, making multiplex assays an efficient tool for comprehensive monitoring and diagnosis. In addition, the global burden of infectious diseases, including viral, bacterial, and emerging pathogens, has increased the need for high-throughput diagnostic solutions capable of detecting multiple pathogens simultaneously. Multiplex reagents allow clinicians to screen for co-infections and identify pathogen profiles in a single test, reducing diagnostic delays. This is particularly important in public health scenarios where early detection can prevent outbreaks. Consequently, growing disease prevalence directly correlates with increased adoption of multiplex testing reagents, thereby driving market expansion.

Technological innovation is a key driver of market growth for multiplex testing reagents. Advanced assay platforms, such as bead-based flow cytometry, microarrays, and next-generation sequencing-compatible reagents, have enhanced the sensitivity, specificity, and throughput of multiplex testing. Automation and integration with laboratory information systems have further streamlined workflows, allowing laboratories to process larger sample volumes with reduced human error. Novel reagent chemistries and labeling techniques have improved the detection of low-abundance biomarkers, expanding clinical and research applications. In addition, miniaturization and microfluidic technologies have enabled point-of-care multiplex testing, bringing laboratory-grade analysis closer to patients. These technological improvements not only improve diagnostic accuracy but also reduce turnaround time and costs, making multiplex testing reagents increasingly attractive for hospitals, diagnostic laboratories, and research institutions globally.

Global Multiplex Testing Reagents Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global multiplex testing reagents market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Biotin-based Reagents
    • Biotinylated Antibodies
    • Biotinylated Probes/primers
    • Biotin-tagged Proteins/enzymes
  • Streptavidin-based Reagents
    • Streptavidin-conjugated Beads/microspheres
    • Streptavidin-conjugated Enzymes & Fluorophores
    • Recombinant Streptavidin Variants (engineered for higher stability)
    • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Autoimmune Disease Diagnostics
  • Infectious Disease Diagnostics
  • Oncology
  • Allergy Testing
  • Research & Translational Medicine
  • Drug Discovery & Development
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical & Diagnostic Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Multiplex Testing Reagents Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. Application Method
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Multiplex Testing Reagents Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type
  • 2.3. Application Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Multiplex Testing Reagents Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Growing demand for precision diagnostics and personalized medicine
    • 3.4.2. Technological advancements in multiplex assay platforms
    • 3.4.3. Rising r&d investments in drug discovery and translational research
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of multiplex assay reagents and equipment
    • 3.5.2. Complex validation and standardization challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Multiplex Testing Reagents Market: Type Estimates & Trend Analysis

  • 4.1. Multiplex Testing Reagents Market: Type Movement Analysis
  • 4.2. Multiplex Testing Reagents Market by Type Outlook (USD Million)
  • 4.3. Biotin-based Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Biotinylated Antibodies
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Biotinylated Probes/primers
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Biotin-tagged Proteins/enzymes
      • 4.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Streptavidin-based Reagents
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Streptavidin-conjugated Beads/microspheres
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Streptavidin-conjugated Enzymes & Fluorophores
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Recombinant Streptavidin Variants (engineered for higher stability)
      • 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Others
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Multiplex Testing Reagents Market: Application Method Estimates & Trend Analysis

  • 5.1. Multiplex Testing Reagents Market: Application Method Movement Analysis
  • 5.2. Multiplex Testing Reagents Market by Application Outlook (USD Million)
  • 5.3. Autoimmune Disease Diagnostics
    • 5.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Infectious Disease Diagnostics
    • 5.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Allergy Testing
    • 5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Research & Translational Medicine
    • 5.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Drug Discovery & Development
    • 5.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Multiplex Testing Reagents Market: End Use Estimates & Trend Analysis

  • 6.1. Multiplex Testing Reagents Market: End Use Movement Analysis
  • 6.2. Multiplex Testing Reagents Market by End Use Outlook (USD Million)
  • 6.3. Clinical & Diagnostic Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Contract Research Organizations (CROs)
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Academic & Research Institutes
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Multiplex Testing Reagents Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Multiplex Testing Reagents Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. Luminex Corporation
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bio-Rad Laboratories, Inc.
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Abcam plc.
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Seegene Inc.
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Merck KGaA
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Illumina, Inc.
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Promega Connections
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. QIAGEN N.V.
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Thermo Fisher Scientific
      • 8.5.9.1. Company Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. PerkinElmer Inc.
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Bio-Techne Corporation
      • 8.5.11.1. Company Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. BD
      • 8.5.12.1. Company Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 4 North America multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 7 U.S. multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 10 Canada multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 13 Mexico multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 17 Europe multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Germany multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 20 Germany multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 22 UK multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 23 UK multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 25 France multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 26 France multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 27 France multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Italy multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 29 Italy multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 31 Spain multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 32 Spain multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Denmark multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 35 Denmark multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Sweden multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 38 Sweden multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Norway multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 41 Norway multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 47 China multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 48 China multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 49 China multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Japan multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 51 Japan multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 52 Japan multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 53 India multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 54 India multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 55 India multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 57 South Korea multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 58 South Korea multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Australia multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 60 Australia multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Thailand multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 63 Thailand multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 64 Thailand multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Latin America multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 66 Latin America multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 67 Latin America multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 68 Latin America multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Brazil multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 70 Brazil multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 71 Brazil multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 72 Argentina multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 73 Argentina multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 74 Argentina multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Middle East & Africa multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 76 Middle East & Africa multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 77 Middle East & Africa multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 78 Middle East & Africa multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 79 South Africa multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 80 South Africa multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 81 South Africa multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 85 UAE multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 86 UAE multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 87 UAE multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Kuwait multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 89 Kuwait multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 90 Kuwait multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Multiplex Testing Reagents Market - Key market driver analysis
  • Fig. 7 Global Multiplex Testing Reagents Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Multiplex Testing Reagents Market - Porter's analysis
  • Fig. 10 Global Multiplex Testing Reagents Market - PESTEL analysis
  • Fig. 11 Global Multiplex Testing Reagents Market Type outlook key takeaways
  • Fig. 12 Global Multiplex Testing Reagents Market: Type movement analysis
  • Fig. 13 Biotin-based Reagents Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Biotinylated Antibodies Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Biotinylated Probes/primers Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Biotin-tagged Proteins/enzymes Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Streptavidin-based Reagents Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Streptavidin-conjugated Beads/microspheres Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Streptavidin-conjugated Enzymes & Fluorophores Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Recombinant Streptavidin Variants (engineered for higher stability) Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Others Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Global Multiplex Testing Reagents Market Application outlook key takeaways
  • Fig. 23 Global Multiplex Testing Reagents Market: Application movement analysis
  • Fig. 24 Autoimmune Disease Diagnostics Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Infectious Disease Diagnostics Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Oncology Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Allergy Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Research & Translational Medicine Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Drug Discovery & Development Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Others Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Global Multiplex Testing Reagents Market End Use outlook key takeaways
  • Fig. 32 Global Multiplex Testing Reagents Market End Use movement analysis
  • Fig. 33 Clinical & Diagnostic Laboratories Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Hospitals Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Pharmaceutical & Biotechnology Companies Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Contract Research Organizations (CROs)
  • Fig. 37 Academic & Research Institutes Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Global Multiplex Testing Reagents Market: Regional movement analysis
  • Fig. 40 North America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 42 Canada Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 45 UK Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 47 France Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 48 Spain Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 49 Italy Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 55 China Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 56 India Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 58 Australia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 62 Argentina Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 63 MEA Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 65 Saudi Arabia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 66 UAE Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 67 Kuwait Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 68 Strategy framework